Cannformatics and Cannabotech Announce the First Clinical Study Using Cannabis-Responsive™ Biomarkers to Evaluate the Impact of "MycoCann NeuroPain" in Managing Chronic Neuropathic Pain

SAN FRANCISCO and HERZLIYA, Israel: SAN FRANCISCO and HERZLIYA, Israel, Aug. 17, 2021 /PRNewswire/ -- Cannformatics, an early-stage biotechnology startup focused on the identification and application of saliva-based Cannabis-Responsive™ biomarkers and Cannabotech, a biomedical company developing medical solutions based on botanical combinations of cannabis extracts and functional mushrooms, today announced...

Click to view original post